EPS for Aethlon Medical (AEMD)

EPS in 2026 (TTM): -₹6,779

According to Aethlon Medical 's latest financial reports the company's current EPS (TTM) is -₹7,285. an increase over its 2025 EPS that were of -₹40,370.

EPS history for Aethlon Medical from 1997 to 2026

Annual EPS

Year	EPS	Change
2026	-₹4,994	-87.63%
2025	-₹40,370	-77.94%
2024	-₹1,82,998	-17.63%
2023	-₹2,22,159	-16.9%
2022	-₹2,67,343	9.23%
2021	-₹2,44,751	-4.51%
2020	-₹2,56,306	-86.11%
2019	-₹18,45,379	1.82%
2018	-₹18,12,357	-61.37%
2017	-₹46,91,349	29.9%
2016	-₹36,11,470	-37.91%
2015	-₹58,16,822	-65.77%
2014	-₹1,69,91,663	110.31%
2013	-₹80,79,161	-58.73%
2012	-₹1,95,78,487	-8.96%
2011	-₹2,15,05,838	-0.09%
2010	-₹2,15,25,451	-36.11%
2009	-₹3,36,90,131	12.37%
2008	-₹2,99,80,289	-47.14%
2007	-₹5,67,12,056	44.41%
2006	-₹3,92,70,205	-0.53%
2005	-₹3,94,79,297	-17.16%
2004	-₹4,76,57,351	-79.43%
2003	-₹23,16,77,160	-38.41%
2002	-₹37,61,54,996	-9.66%
2001	-₹41,63,65,986	15558.32%
2000	-₹26,59,072	244.4%
1999	-₹7,72,080	-98.33%
1998	-₹4,63,02,372	31964.67%
1997	-₹1,44,403

EPS for similar companies or competitors

Company	EPS	EPS differencediff.	Country
PerkinElmer PKI	₹724.82	-109.95%	🇺🇸 USA
Pacific Biosciences PACB	-₹40.48	-99.44%	🇺🇸 USA
Coherent Corp. COHR	₹409.49	-105.62%	🇺🇸 USA
Bruker BRKR	-₹65.89	-99.10%	🇺🇸 USA
Accelerate Diagnostics AXDX	-₹166.62	-97.71%	🇺🇸 USA
Inovio Pharmaceuticals INO	-₹172.27	-97.64%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions